FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

40552311000001102: Dostinex 500microgram tablets (CST Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Mar 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2028991000001119 Dostinex 500microgram tablets (CST Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2029001000001119 Dostinex 500microgram tablets (CST Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dostinex 500microgram tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (CST Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (CST Pharma Ltd) Is a Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (CST Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (CST Pharma Ltd) Is a Dostinex true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (CST Pharma Ltd) Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (CST Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (CST Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (CST Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dostinex 500microgram tablets (CST Pharma Ltd) 8 tablet Has AMP True Dostinex 500microgram tablets (CST Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start